The prospectus is not for release, publication or distribution, directly or indirectly, in or into the United States, Canada, Japan or Australia or any other jurisdiction in which such release, publication or distribution would be unlawful.
Neither the delivery of the prospectus nor the issue, sale or delivery of any note shall, in any circumstances, create any implication that the information contained in the prospectus is true subsequent to the date hereof or, if the prospectus is supplemented after the date hereof, the date of the relevant supplement or that there has been no adverse change, or any event reasonably likely to involve any adverse change, in the prospects or financial or trading position of Novo Nordisk A/S since the date thereof or, if the prospectus is supplemented after the date hereof, the date of the relevant supplement or that any other information supplied in connection with the notes is correct at any time subsequent to the date on which it is supplied or, if different, the date indicated in the document containing the same.
The prospectus is not intended to provide the basis of any credit or
any other evaluation and should not be considered as a recommendation
by Novo Nordisk A/S that any recipient of the prospectus should invest
in the notes. Prospective investors should make an independent
assessment as to whether the information in the prospectus is relevant
to their situation, and any investment in the notes should be based on
the information regarding the investor's specific circumstances that
the investor may deem necessary and only if the notes are consistent
with the investor’s financial objectives.
The distribution of the prospectus and the offering or sale of notes
in certain jurisdictions may be restricted by law. The prospectus may
not be distributed or otherwise made available and the notes may not
be offered or sold, directly or indirectly, in any jurisdiction,
unless such distribution, offering or sale is permitted under
applicable laws in the relevant jurisdiction.
The notes have not been and will not be registered under the United
States Securities Act of 1933, as amended (the "Securities
Act") and may not be offered or sold within the United States or
to, or for the account or benefit of, U.S. persons except in certain
transactions exempt from the registration requirements of the